1.
Möller B, Becker L-L, Saffari A, et al. The expanding clinical and genetic spectrum of DYNC1H1-related disorders. Brain : a journal of neurology. 2024. doi:10.1093/brain/awae183.
1.
Guo B, Liu T, Choi S, et al. Restoring thalamocortical circuit dysfunction by correcting HCN channelopathy in Shank3 mutant mice. Cell reports. Medicine. 2024:101534. doi:10.1016/j.xcrm.2024.101534.
1.
Guo B, Liu T, Choi S, et al. Restoring thalamocortical circuit dysfunction by correcting HCN channelopathy in Shank3 mutant mice. Cell reports. Medicine. 2024:101534. doi:10.1016/j.xcrm.2024.101534.
1.
Favuzzi E, Huang S, Saldi GA, et al. GABA-receptive microglia selectively sculpt developing inhibitory circuits. Cell. 2021;184(15):4048-4063.e32. doi:10.1016/j.cell.2021.06.018.
1.
Scala M, Khan K, Beneteau C, et al. Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities. Genetics in medicine : official journal of the American College of Medical Genetics. 2023:101057. doi:10.1016/j.gim.2023.101057.
1.
Mekbib KY, Muñoz W, Allington G, et al. Human genetics and molecular genomics of Chiari malformation type 1. Trends in molecular medicine. 2023. doi:10.1016/j.molmed.2023.08.013.
1.
Sanchis-Juan A, Megy K, Stephens J, et al. Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders. American journal of human genetics. 2023;110(8):1343-1355. doi:10.1016/j.ajhg.2023.07.007.
1.
Khalil R, Kenny C, Hill S, et al. PSMD12 haploinsufficiency in a neurodevelopmental disorder with autistic features. Am J Med Genet B Neuropsychiatr Genet. 2018;177(8):736-745. doi:10.1002/ajmg.b.32688.
1.
D’Gama AM, Walsh CA. Somatic mosaicism and neurodevelopmental disease. Nat Neurosci. 2018;21(11):1504-1514. doi:10.1038/s41593-018-0257-3.
1.
Singh T, Poterba T, Curtis D, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604(7906):509-516. doi:10.1038/s41586-022-04556-w.